Non-invasive MRD Assessment in Multiple Myeloma

Non-invasive MRD Assessment in Multiple Myeloma
Myeloma Group

Patients with newly diagnosed and previously treated multiple myeloma will receive bone marrow sampling and functional imaging.

Other: MRD Assessment

MRD assessment includes liquid biopsy and functional imaging. Liquid biopsy will be performed by the Adaptive ClonoSEQ® assay in peripheral blood. Functional imaging will be performed by whole body diffusion-weighted magnetic resonance imaging (WB-DWI).

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 24, 2022Comments | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine